Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
100 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2023-04-27 | 2023-07-21 | 190782 |
| TEVA-AZATHIOPRINE | 50MG | TABLET | Resolved | 2019-11-28 | 2020-03-05 | 99941 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Resolved | 2017-08-01 | 2025-04-25 | 17856 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2017-08-01 | 2017-10-11 | 17859 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2017-08-21 | 2017-10-11 | 19931 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-06-19 | 2023-06-21 | 195512 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2023-10-26 | 2023-11-23 | 208254 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2023-10-26 | 2023-11-03 | 208257 |
| TEVA-BETAHISTINE | 8MG | TABLET | Actual shortage | 2024-10-11 | 2024-10-22 | 240053 |
| TEVA-BETAHISTINE | 16MG | TABLET | Actual shortage | 2024-10-22 | 2024-10-23 | 240877 |
| TEVA-BETAHISTINE | 24MG | TABLET | Actual shortage | 2024-10-22 | 2024-10-23 | 240880 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2020-08-13 | 2020-10-08 | 122194 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2020-08-13 | 2020-10-08 | 122198 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2020-09-03 | 2020-10-15 | 123723 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2020-09-24 | 2020-11-26 | 124956 |
| TEVA-BETAHISTINE | 24MG | TABLET | Resolved | 2024-02-01 | 2024-04-25 | 218129 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2024-06-27 | 2024-07-26 | 231427 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2024-07-04 | 2024-07-26 | 232220 |
| TEVA-BETAHISTINE | 8MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160986 |
| TEVA-BETAHISTINE | 16MG | TABLET | Resolved | 2022-05-19 | 2022-05-21 | 160989 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |